Work

Supplementary Figure 1 from Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Figure 1. Patients with new iodine uptake after four weeks of dabrafenib.

DOI: 10.1158/1078-0432.22460076

Authors: S. Michael Rothenberg, David G. McFadden, Edwin L. Palmer, Gilbert H. Daniels, Lori J. Wirth

Language: English

Topic: Thyroid Cancer Diagnosis and Treatment

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362397819

Cites:

Cited by:

Related to: 10